Zdrowie i gospodarka · 11/08/2000

FDA Releases Draft Guidance for Botanical Drug Products

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the circumstances under which a new drug application is required for marketing a botanical drug product, as well as guidance for conducting clinical investigations of these products.